Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Health Canada has approved 👏us, FDA won’t be far behind 🚀
View:
Post by jopatclo on Aug 26, 2024 8:30am

Health Canada has approved 👏us, FDA won’t be far behind 🚀

Great comment from Miro Cernetig on Linkedin from Hugh's repost (A.I. is going to vastly improve health care for everyone. One application, now in use, is Ventripoint. It turns ultrasounds of the heart into detailed images that are created in a fraction of the time and cost of using an MRI. It's of real importance in the treatment of infants and children with heart conditions. is a great made-in-Canada technology now being used in hospitals in Canada, the U.S., U.K. and Europe)

post Hugh (Yesterday I had the pleasure working with our Clinical Applications Manager Cristina Almeida during her upgrade of the system at the Seattle Children's Hospital to the new magnet-less sensors. It was a great opportunity to visit a customer site, observe and learn about their clinical environment and workflows, and discuss future development plans.) and now remember health Canada has approved us, FDA won’t be far behind. The visionary Dr. G. Adams and Alvira M. have done the long work that had to be done during all these years for Ventripoint to arrive V4.0 Bravo procurement in healthcare is complex . FDA V4.0 and Sales at any time now Insiders know!
Comment by jopatclo on Aug 27, 2024 9:44am
Interesting for Ventripoint https://www.asecho.org/echoinpchd/ American Society of EchocardiographyAmerican Society of Echocardiography29,846 followers29,846 followers19h • 19 hours ago   Coming October 26-27, our 3rd Annual Echo in PCHD will present the latest information on established and emerging cardiovascular ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities